• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Use of polylactic acid for the preparation of microparticulate drug delivery systems.

作者信息

Conti B, Pavanetto F, Genta I

机构信息

Department of Pharmaceutical Chemistry, University of Pavia, Italy.

出版信息

J Microencapsul. 1992 Apr-Jun;9(2):153-66. doi: 10.3109/02652049109021231.

DOI:10.3109/02652049109021231
PMID:1593398
Abstract

This report reviews the development of particulate drug delivery systems technology based on polylactic acid (PLA). The following methods used to produce PLA microparticles are considered: emulsion solvent evaporation, emulsion solvent extraction, interfacial phase deposition, spray coating, and the melting method. The different preparation processes and parameters used, the characteristics of microparticles obtained and those parameters affecting the characteristics of these systems, are discussed.

摘要

相似文献

1
Use of polylactic acid for the preparation of microparticulate drug delivery systems.
J Microencapsul. 1992 Apr-Jun;9(2):153-66. doi: 10.3109/02652049109021231.
2
Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.微囊化方法和肽负载对聚乳酸和聚乳酸-乙醇酸共聚物体外测试期间降解的影响。
J Control Release. 1998 Feb 12;51(2-3):327-41. doi: 10.1016/s0168-3659(97)00188-0.
3
Recent advances in the preparation progress of protein/peptide drug loaded PLA/PLGA microspheres.载蛋白/肽药物的聚乳酸/聚乳酸-羟基乙酸共聚物微球制备进展的研究近况
Yao Xue Xue Bao. 2007 Jan;42(1):1-7.
4
PHEA-PLA biocompatible nanoparticles by technique of solvent evaporation from multiple emulsions.通过复乳溶剂蒸发技术制备的PHEA-PLA生物相容性纳米颗粒。
Int J Pharm. 2015 Nov 30;495(2):719-27. doi: 10.1016/j.ijpharm.2015.09.050. Epub 2015 Sep 26.
5
[Preparation of peroral sustained release drug forms on a base of biodegradable polymers. 1. Preparation and characterization of polylactic acid].基于可生物降解聚合物的口服缓释药物剂型的制备。1. 聚乳酸的制备与表征
Pharmazie. 1989 Apr;44(4):276-9.
6
Preparation of multi-phase microspheres of poly(D,L-lactic acid) and poly(D,L-lactic-co-glycolic acid) containing a W/O emulsion by a multiple emulsion solvent evaporation technique.采用复乳溶剂挥发法制备含油包水型乳液的聚(D,L-乳酸)和聚(D,L-乳酸-共-乙醇酸)多相微球。
J Microencapsul. 1992 Apr-Jun;9(2):201-14. doi: 10.3109/02652049109021237.
7
Nimesulide PLA microspheres as a potential sustained release system for the treatment of inflammatory diseases.尼美舒利聚乳酸微球作为一种治疗炎症性疾病的潜在缓释系统。
Int J Pharm. 2005 May 13;295(1-2):201-11. doi: 10.1016/j.ijpharm.2005.03.003.
8
Low molecular weight PLA: a suitable polymer for pulmonary administered microparticles?低分子量聚乳酸:一种适用于肺部给药微粒的聚合物?
J Microencapsul. 1993 Apr-Jun;10(2):195-207. doi: 10.3109/02652049309104385.
9
A novel in situ forming drug delivery system for controlled parenteral drug delivery.一种用于可控非肠道给药的新型原位形成药物递送系统。
Int J Pharm. 2007 Mar 6;332(1-2):107-14. doi: 10.1016/j.ijpharm.2006.09.033. Epub 2006 Sep 26.
10
Preliminary investigation on the design of biodegradable microparticles for ivermectin delivery: set up of formulation parameters.用于伊维菌素递送的可生物降解微粒设计的初步研究:配方参数的设定
Drug Dev Ind Pharm. 2015;41(7):1182-92. doi: 10.3109/03639045.2014.935395. Epub 2014 Jul 4.

引用本文的文献

1
Ocular biocompatibility and structural integrity of micro- and nanostructured poly(caprolactone) films.微纳米结构聚己内酯薄膜的眼生物相容性和结构完整性。
J Ocul Pharmacol Ther. 2013 Mar;29(2):249-57. doi: 10.1089/jop.2012.0152. Epub 2013 Feb 7.
2
Optimization of experimental parameters for the production of LMWH-loaded polymeric microspheres.用于制备载低分子量肝素聚合物微球的实验参数优化。
Drug Des Devel Ther. 2009 Feb 6;2:39-47.
3
Attachment of an aminoglycoside, amikacin, to implantable collagen for local delivery in wounds.
将氨基糖苷类药物阿米卡星附着于可植入胶原蛋白上,用于伤口局部给药。
Antimicrob Agents Chemother. 1993 Sep;37(9):1890-5. doi: 10.1128/AAC.37.9.1890.
4
Noncytotoxic combinations of topical antimicrobial agents for use with cultured skin substitutes.与培养皮肤替代物联合使用的局部抗菌剂的无细胞毒性组合。
Antimicrob Agents Chemother. 1995 Jun;39(6):1324-8. doi: 10.1128/AAC.39.6.1324.